Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer

Activation of T cell immune response is critical for the therapeutic efficacy of cancer immunotherapy. Current immunotherapies have shown remarkable clinical success against several cancers; however, significant responses remain restricted to a minority of patients. Here, we show a therapeutic strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Gi-Hoon, Lee, Eun Jung, Kim, Yoon Kyoung, Hong, Yeonsun, Choi, Yoonjeong, Ryu, Myung-Jeom, Woo, Jiwan, Cho, Yakdol, Ahn, Dong June, Yang, Yoosoo, Kwon, Ick-Chan, Park, Seung-Yoon, Kim, In-San
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986820/
https://www.ncbi.nlm.nih.gov/pubmed/29867097
http://dx.doi.org/10.1038/s41467-018-04607-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986820/
https://www.ncbi.nlm.nih.gov/pubmed/29867097
http://dx.doi.org/10.1038/s41467-018-04607-9

Ejemplares similares